ISRCTN26286159已完成不适用
TUmor Necrosis factor blockaDe in patients with Rheumatoid Arthritis inhibits atherothrombosis
Academic Medical Center (AMC) (The Netherlands)0 个研究点目标入组 15 人开始时间: 2007年1月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Male or female patients who were priorly diagnosed with RA, who are currently experiencing an inflammatory episode and who will be treated with TNF-alpha blockade
- •2. Age 18 to 80 years
排除标准
- •1. Patients who were priorly diagnosed with diabetes, hypertension or cardiovascular disease
- •2. Current signs or symptoms of severe, progressive or uncontrolled hepatic, haematological, gastroenterological, endocrine, pulmonary, cardiac or neurological disease
研究者
相似试验
已完成
不适用
Tumor Necrosis Factor blockade in patients with Rheumatoid Arthritis inhibits Atherothrombosis.Rheumatoid ArthritisNL-OMON29079Academic Medical CenterAmsterdam, the Netherlands15
进行中（未招募）
1 期
To see whether for patients with established rheumatoid arthritis that have already achieved a good response to Tumour Necrosis Factor Inhibitor (TNF inhibitor) treatment, whether the treatment be tapered to a minimum dose without affecting the control of disease activity.EUCTR2010-020738-24-GBKing's College London97
进行中（未招募）
1 期
Anti-TNF discontinuation in patients with inflammatory bowel diseaseInflammatory bowel diseaseMedDRA version: 19.0Level: LLTClassification code 10021973Term: Inflammatory bowel disease NOSSystem Organ Class: 100000004856EUCTR2015-001410-10-ESFundación de Investigación Biomédica Hospital Universitario de la Princesa300
招募中
不适用
Impact of anti-tumor necrosis factor antibodies treatment on the semen quality of inflammatory bowel diseases patientsfertilityreproduction10013356NL-OMON33788Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
2 期
Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19COVID-19.COVID-19U07.1IRCT20200312046749N1Tehran University of Medical Sciences80